Manikanda Arunachalam

Dr. Manikanda Arunachalam is a multi disciplinary professional with expertise in Venture capital and private equity with sectoral interest in Healthcare , Hightech and Artificial Intelligence.

Dr. Mani is a Managing Partner in Lotus Capital, A global Multi family office that provides investment advisory services and asset management to most influential families in North America, GCC region and Asia.

Dr. Mani served as the SVP Corporate Development and Investments and Head of Healthcare at Beyond Limits, An Artificial Intelligence Engineering Company based in Southern California. He continues as a strategic advisor.

Mani serves as the Chief Investment advisor to Arkon Holdings and Raycomgroup where he focuses in portfolio management as well as healthcareand technology investments.

Mani Serves as Chief Strategist for Securra Inc where he guides the CEO and Senior Management in Product, technology and solutions architecture as well as commercialization, Global partnerships and alliances

Mani serves as a strategic Advisor toL ife Signals Group

Mani served as a board of Director in The KEF company, a multi million dollar private investment firm in Dubai International Financial center (DIFC). At KEF company Mani overseas the Healthcare investment portfolio and as a key strategist in managing the healthcare investments.

Mani Served as an Operating Partner in Capricorn Healthcare and Special opportunities(CHSO) Fund. CHSO is a health care middle market growth equity fund in Palo Alto.

Earlier Mani served as a board of director in Motherhood India, a chain of boutique mother and delivery care hospital, where he was responsible for capital raising through private equity placement and corporate strategy and planning. TPG acquired significant stake of Motherhood in 2016.

Mani worked as a strategic management consultant and has advised Provider organizations, biotech and Medical devices firms. Currently serves on the board of HD medical group and Strategic advisor to Guardant Health.

Earlier he worked for Johnson and Johnson Medical devices where he was responsible for technology and portfolio management.

Mani started his career as a Cardiologist at the Apollo hospitals group in Chennai where he was trained in intervention cardiology. He was one of the pioneers in conducting multinational clinical trials as an investigator for Eli Lilly, Servier and Covance.

Mani Holds a MD degree from Prestigious Madras Medical college where he graduated among the top 5% of the class, Fellowship in Cardiology and an MBA ( Finance & Strategy)from the Wharton School of The University of Pennsylvania.